Methods of Diagnosis and Prognosis for a Muscular Dystrophy

The invention relates to the treatment, diagnosis, and prognosis of a muscular dystrophy or myopathy. The present inventors have found that the quantity of mu-crystallin is increased in a muscular dystrophy. In particular, the inventors have found that mu-crystallin is increased in facioscapulohumeral muscular dystrophy (FSHD). Based on the inventors' findings, the invention provides a novel means for the treatment, diagnosis, and prognosis of a muscular dystrophy or myopathy.

Attached files:
US 20090280517.jpg

Patents:
US 20,090,280,517

Inventor(s): BLOCH ROBERT J [US]; REED PATRICK W [US]

Type of Offer: Licensing



Next Patent »
« More Diagnostic Patents

Share on      


CrowdSell Your Patent